CM
JAZZ icon

CastleKnight Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

CastleKnight Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87M Hold
11,900
– – 0.04% 259
2026
Q1 		$2.25M Hold
11,900
– – 0.04% 268
2025
Q4 		$2.02M Sell
11,900
-2,800
-19% -$429K 0.04% 192
2025
Q3 		$1.94M Buy
14,700
+4,400
+43% +$528K 0.04% 239
2025
Q2 		$1.09M Buy
+10,300
New +$1.12M 0.03% 286

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CastleKnight Management's JAZZ Position: Q2 2026 in Review

CastleKnight Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 11,900 shares worth $2.87M. The position accounts for 0.04% of the portfolio, ranked #259.

CastleKnight Management first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • CastleKnight Management held 11,900 shares of Jazz Pharmaceuticals worth $2.87M as of Q2 2026.
  • CastleKnight Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.04% of CastleKnight Management's portfolio in Q2 2026, its #259 holding.
  • CastleKnight Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.